News

Project event

Updated on April 04, 2016

The National Institute of Advanced Industrial Science and Technology (AIST) developed a technology for evaluation of differentiation potential of human mesenchymal stem cells (hMSC)

On April 4, 2016, AIST, a member of SCA, made a press release announcing that it developed a technology for simple and rapid evaluation of differentiation potential of hMSC. The technology is expected to contribute to industrialization of regenerative medicine using hMSC.  The details were published online in an American scientific journal, Glycobiology (2016) April 2.